Matt Biegler

Stock Analyst at Oppenheimer

(n/a)

# 4,946

Out of 5,242 analysts

3

Total ratings

n/a

Success rate

-58.48%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Matt Biegler

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	OKUR OnKure Therapeutics	Maintains: Outperform	$35 → $30	$3.56	+742.70%	2	Mar 11, 2025
	ALLO Allogene Therapeutics	Maintains: Outperform	$11 → $10	$1.90	+426.32%	1	Nov 8, 2024

OnKure Therapeutics

Mar 11, 2025

Maintains: Outperform

Price Target: $35 → $30

Current: $3.56

Upside: +742.70%

Allogene Therapeutics

Nov 8, 2024

Maintains: Outperform

Price Target: $11 → $10

Current: $1.90

Upside: +426.32%